SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Chordia Therapeutics Posts 1.45 Billion Yen Parent Recurring Loss

Chordia Therapeutics reported a parent recurring loss of 1.45 billion yen for 2025/26, versus a loss of 1.77 billion yen.

Related stories